Adial Pharmaceuticals (ADIL)
(Real Time Quote from BATS)
$1.05 USD
-0.04 (-3.67%)
Updated Jul 22, 2024 01:20 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ADIL 1.05 -0.04(-3.67%)
Will ADIL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ADIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADIL
Is Masimo (MASI) Outperforming Other Medical Stocks This Year?
All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy
ADIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Adial (ADIL) Shares Up 43% in the Past Week: Here's Why
Is Adial Pharmaceuticals (ADIL) Stock Outpacing Its Medical Peers This Year?
Adial Pharmaceuticals, Inc. (ADIL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Other News for ADIL
ADIL Stock Earnings: Adial Pharmaceuticals Beats EPS for Q4 2023
Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder
Adial Pharmaceuticals announces publication on efficacy of AD04
EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder
Biotech Alert: Searches spiking for these stocks today